Skip to main content

Deep dive: How microbiome balance drives health outcomes

The microbiome is a dynamic ecosystem, not a collection of individual species

Inside every person lives a vast community of microorganisms — mostly bacteria, along with
fungi, viruses and archaea — collectively called the microbiome. This community is densest in
the gut, especially the colon, where trillions of microbes interact with each other and with their
human host. 1,2

Rather than acting as isolated species, these microbes form an ecosystem that adjusts to diet,
medications, infections, stress and other exposures. The functional profile of this ecosystem
depends on many moving parts: which microbes are present, how they interact, what fuels they
receive, the gut environment, and which metabolic activities are turned on at any given time. In
turn, these metabolic outputs shape host physiology and can promote health or, if out of
balance, may contribute to symptoms and disease processes.3,4

 

001

pH modulation

Production of acids and SCFAs lowers luminal pH, making the colon less hospitable for certain harmful bacteria.

002

Antimicrobial compounds

Generation of bacteriocins and other compounds that directly inhibit competitors.

003

Barrier maintenance

Support of the mucus layer and gut barrier, limiting pathogen and toxin access to the intestinal wall.

004

Immune priming

Promotion and priming of innate immune cells, enabling faster response to enteric infection.

When diversity is reduced — after antibiotics, severe illness or restrictive diets — this protective network can weaken. With fewer competitors and less functional redundancy (fewer microbes able to perform the same protective functions), opportunistic organisms may gain a foothold and, in some cases, establish infection or persistent colonisation.

Clinical example

Impaired colonisation resistance has been linked to greater susceptibility to post-infectious IBS following gastroenteritis, with some individuals experiencing long-term symptoms after an acute infection. 9,10

Diet determines what the microbiome produces

Fibre fermentation and health-supporting metabolites

What microbes do is strongly influenced by what they are fed. Many dietary fibres cannot be
digested by human enzymes but can be fermented by gut microbes. When bacteria ferment
complex carbohydrates, they can produce short-chain fatty acids such as acetate, propionate
and butyrate.11,12

 

 

Critically, the gut microbiota is metabolically flexible. Microbes that produce beneficial metabolites from dietary fibre can shift towards less favourable outputs when the diet is low in fermentable carbohydrates and high in protein or fat. Different fibres (resistant starch, inulin, arabinoxylans) favour different microbial groups and can shift SCFA profiles, so the type and diversity of fibre matter as much as total fibre intake.

Clinical example

Impaired colonisation resistance has been linked to greater susceptibility to post-infectious IBS following gastroenteritis, with some individuals experiencing long-term symptoms after an acute infection. 9,10

001
Birth

Initial microbial colonisation begins
immune education

002
Early childhood

Diverse exposure builds tolerance and
regulatory pathways

003
Adulthood

Ongoing immune modulation through
microbial metabolites and signalling

SCFAs

Promote regulatory T cells and reduce certain pro-inflammatory cytokines

Tryptophan metabolites

Signal through aryl hydrocarbon receptors influencing innate lymphoid cells and local immune responses

LPS variants

Different structural forms can trigger inflammatory signalling or elicit regulatory immune responses

When the microbiome is balanced, these signals usually support a steady, controlled immune state. When microbial composition and function are disrupted, signalling may become skewed in ways that can contribute to chronic inflammation in susceptible individuals.24

Clinical example
In oncology, gut microbiome composition has been linked to better or worse responses to
immunotherapy, suggesting microbial immune modulation can influence treatment outcomes.

Health outcomes depend on microbial cooperation

Cross-feeding and microbial cooperation

Many clinically relevant metabolites are not produced by a single microbe acting alone. Instead, they arise through cross-feeding, where one species’ metabolic by-products become another species’ fuel. For example, fibre fermentation by Bifidobacterium spp. can generate acetate and lactate that is then converted into butyrate by butyrate-producing Firmicutes such as Faecalibacterium prausnitzii, Roseburia and Eubacterium.28

 

This distributed architecture also helps explain how microbial communities become more stable 
and resilient to disturbances, and how people with very different species profiles can still display similar functional capacities: different microbial “teams” can lead to similar metabolic outcomes.

Functional potential only becomes
functional reality when the right conditions align

Modern sequencing technologies can estimate the microbiome’s functional potential by identifying genes and pathways — a valuable starting point. However, this potential must be realised through the right conditions, and especially fuel source availability.

What bacteria produce depends heavily on available substrates: when fermentable carbohydrates are plentiful, SCFA production often increases; but when dietary fibre is limited, proteolytic fermentation pathways can become more prominent.11

CLINICAL EXAMPLE

Individuals with higher butyrate-producing capacity may show greater response and metabolic benefit when diets provide matching fermentable fibres, illustrating how diet can “unlock” functional capacity.31,32,33

Functional balance

SCFA production, immune regulation, barrier maintenance and colonisation resistance are robust. Pathways generating potentially harmful metabolites are kept in check.

Functional dysbiosis

Beneficial activities are reduced and potentially damaging or symptom-linked functions are increased. Associated with distinct changes in metabolic functions linked to inflammation.35,36,37,38
A functional microbiome lens helps explain why the same intervention — higher fibre intake, probiotics or medication — may help one person but worsen symptoms in another, depending on microbial functions, dietary context and host factors. Supporting health often means working with the ecosystem: providing the right fuels, avoiding unnecessary disruptions, and using targeted strategies to shift microbial functions rather than chasing or eradicating individual species.

The microbiome is a dynamic ecosystem whose functions — not just its composition — shape human health

Diverse, well-balanced communities support colonisation resistance, 
helping defend against pathogens

Fibre fermentation produces beneficial SCFAs, while protein fermentation produces a spectrum of metabolites depending on substrate availability and community context

Microbes and the immune system are in continuous dialogue — microbial metabolites help train, tune and sometimes misdirect immune responses

Many important pathways rely on cross-feeding and cooperation across species, meaning community structure and resource availability determine which functions are expressed

Functional potential only becomes functional reality when the right fuels and conditions align

A functional ecosystem-based lens supports more personalised, targeted strategies to maintain or restore health

Key POINT

The microbiome is a dynamic ecosystem whose functions — not just its composition — shape human health. Diverse communities support colonisation resistance, diet determines metabolic outputs, and health outcomes depend on community cooperation and functional balance rather than individual species.1,3

Already have an account? Log in. Log in
New to Microba? Sign up today. Sign up to start referring